Skip to main content
Clinical Trials/IRCT2017012132081N2
IRCT2017012132081N2CompletedPhase 1

Survey the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with moderate persistent allergic asthma

Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences0 sites86 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
86

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • age between 18 to 65 years old, moderate persistent allergic asthma (FEV1 between 40 to 60 percent) according to the physician and normal BMI (up to 27). Inclusion criteria dos not belong to the particular gender and include male and females.
  • Exclusion criteria include smoking, diabetes, pregnancy and lactation, autoimmune disease, malignancies, gastrointestinal, liver and kidney disease, pneumonia and other pulmonary disease and Not wanting to continue cooperation

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences

Similar Trials